The headline numbers for Celanese (CE) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street es...

Celanese (CE) is expected to have benefited from its cost actions and contributions of acquisitions amid demand headwinds in certain markets in Q3.

Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Celanese Corporation is a global leader in the production of acetyl products and engineered materials. The company faces challenges due to a stretched balance sheet and near-term macro uncertainty....

Celanese (CE) benefits from its productivity measures, investments in organic projects and strategic acquisitions.

Celanese (CE) monetizes the majority of its Food Ingredients business while maintaining the demand benefits of raw material integration with the Acetyl Chain.

My mission, should I choose to accept it, is to find the three most undervalued materials stocks to buy in September. Dr. Ed Yardeni and his capable crew at Yardeni Research produce interesting cha...

The VitalDose platform by Celanese (CE) Delivery Platform has a long history of application in approved parenteral drug options.

Celanese (CE) reported earnings 30 days ago. What's next for the stock?

Celanese (CE) is refinancing its debt to extend the maturity of its debt and reduce its borrowing costs by 14 basis points.

Celanese (CE) misses second-quarter earnings and sales estimates due to slow demand recovery and production cuts.